We all know who they deepstate are, they are hidden bureaucrats in government, business, leaders, heads of agencies and many below them, etc..The SES is the deepest of DS. Why are you asking questions on this? sure we may never find them all, but "Trump caught them all". What more do you need to know.
District of Columbia lawmakers consider giving residents as much as $1,200 to buy an electric bike
Under the bill, applicants would need to provide "proof of residency and proof of household income to be eligible for the program," according to the local news
By Nicholas Ballasy
Updated: January 18, 2023 - 1:50pm
The District of Columbia city council is considered a proposal to give residents up to $1,200 to buy electric bikes.
Under the bill, applicants would need to provide proof of residency and household income to be eligible for the program, according to local news reports.
Council member Brooke Pinto, a Democrat who proposing the measure, the E-BIKE Act, said the legislation is "aimed at reducing cost-barriers that prevent residents from purchasing an electric bike while supporting small business owners here in DC."
She also said the bill is related the expansion of bike lanes in the the nation's capital.
"As we continue to invest in our protected bike lane network, this legislation is crucial to ensuring as many residents as possible can benefit from this expanded infrastructure," Pinto also said.
According to the legislation, residents earning 80% or more of the median family income would be eligible for instant rebates of "up to $400 or 30% of the bike's purchase price – whichever is lower or $500 for cargo electric bicycle models."
Residents with annual earnings below 80% of the median family income in D.C. could receive up to $1,200, or 75% of the price e-bike of the bike.
https://justthenews.com/government/local/dc-bill-would-give-residents-1200-buy-electric-bikes
Nevada county considers banning COVID, flu vaccines
One Elko County Board of Health commissioner said he thinks the proposals should have never been placed on the agenda.
Updated: January 18, 2023 - 12:08pm
A Nevada county health board is scheduled to meet Wednesday to consider implementing a moratorium on COVID-19 and flu vaccines.
Elko County, Nev., health officials are also going toconsider discontinuing local advertising promoting COVID and flu shots"pending further investigation and results of the Florida Supreme Court case to investigate the wrong doing related to COVID-19 vaccines," according to the meeting agenda.
The Florida Supreme Court last month approved a request from Gov. Ron DeSantis (R-Fla.) for a grand jury to probe COVID vaccine manufacturers. DeSantis previously said he will hold the manufacturers "accountable" for alleged severe COVID vaccine side effects.
Elko County Board of Health Commissioner Jon Karr said he thinks the proposals should have never been placed on the agenda.
"We’ve already been notified by legal that we don’t have the authority to issue a moratorium," Karr told the Las Vegas Review-Journal. "I believe it’s just a miscommunication, and I’m hoping it gets tabled indefinitely."
Another Elko County Board of Health commissioner, Delmo Andreozzi, said: "We do not regulate or have any direct oversight of the health care industry."
"It is my own personal belief that an individual’s health care decisions should only be made in consultation with that individual’s own medical provider for ANY and ALL health care matters," Andreozzi wrote in an email to the local outlet.
Elko County has a population of nearly 54,000, according to Census data.
https://justthenews.com/politics-policy/coronavirus/nevada-county-considers-banning-covid-flu-vaccines
Medical group finds U.S. significantly more permissive in child transgender treatment than Europe
U.S. should "reconsider" its approach to gender treatment, group says.
Updated: January 18, 2023 - 11:57am
A medical advocacy group said in a new report this month that the United States is an outlier compared to much of Europe in its broadly permissive approach to radical transgender treatments for young children.
The group, Do No Harm, said in its report "Reassigned" that many northern and western European countries "share the United States’ broad support for transgenderism," yet those nations nevertheless "reject the gender-affirming care model for children" that is prevalent in the United States.
That "care model" includes the practice of "puberty blockers, cross-sex hormones, and sex reassignment surgeries," which multiple nations in Europe have lately been rejecting in favor of more careful and evidence-based treatment.
"In fact, several countries, including the United Kingdom, Sweden, and Finland,have explicitly abandoned it in recent years in part due to fear that medical intervention has become overprescribed," the report says.
"In a sharp departure from the gender affirmation model employed in the United States, these countries now discourage automatic deference to a child’s self-declarations on the grounds that the risks outweigh the benefits, while also calling for months-long psychotherapy sessions to address co-occurring mental health problems," it continues.
The United States, meanwhile, is "the most permissive country" among all of them "when it comes to the legal and medical gender transition of children."
The U.S. "should reconsider the gender- affirming care model to protect the youngest and most vulnerable patients," the group said.
https://justthenews.com/politics-policy/health/medical-group-finds-us-significantly-more-permissive-child-transgender
Graham, McMaster to join Trump at his first public 2024 presidential campaign rally(Why Graham)
Trump's previous appearances have been virtual or in front of invited guests in Mar-a-Lago, Florida.
Updated: January 18, 2023 - 8:24am
Former President Trump will be joined by Sen. Lindsey Graham and Gov. Henry McMaster, South Carolina Republicans, at his first public 2024 presidential campaign event.
Trump plans to unveil his South Carolina leadership team at the Jan. 28 event in Columbia, S.C., his campaign announced Tuesday. He will also be joined by state lawmakers and members of the South Carolina Republican congressional delegation.
GOP Reps. Russel Fry and William Timmons are among those who have already confirmed they will attend, according to The Associated Press.
The rollout, which is Trump's first public campaign event since launching his 2024 bid in November, is scheduled to have "500 attendees," according to South Carolina state officials. Trump's previous appearances have been virtual or in front of invited guests at his home in Mar-a-Lago, Florida.
https://justthenews.com/politics-policy/all-things-trump/graham-mcmaster-join-trump-first-public-2024-presidential-campaign
Pfizer, Fauci staffers sign off on research finding mRNA COVID vaccines produce worse antibodies 1 of 2
Second study in a month to find "class switch" to so-called IgG4 antibodies, known for their mild immune response, in mRNA recipients alone. Future of Johnson & Johnson's traditional vaccine unclear as demand craters.
Updated: January 17, 2023 - 11:24pm
Less than a month after the CDC marked the two-year anniversary of the first administered COVID-19 vaccine by telling Americans to get a bivalent booster, two peer-reviewed German studies have foundthat mRNA vaccines — the vast majority of the U.S. market — induce worse antibodies compared to traditional adenovirus vaccines.
The first paper, published in Science Immunology Dec. 22, focused on mRNA boosters, while the second, published in Frontiers in Immunology Jan. 12, found the same association with the two-dose primary series.
The Frontiers paper has the added distinction of a Pfizer scientist serving as its editor and one of Anthony Fauci's staffers at the National Institute of Allergy and Infectious Diseases as a peer reviewer, suggesting the mRNA vaccine maker and feds were aware of a potential antibody problem around the time Omicron-targeting boosters were authorized.
The findings call into question the government's promotion of bivalent boosting even while regulators admit that newer COVID variants are evading vaccines.
New York City's Department of Health told residents Friday the XBB.1.5 Omicron subvariant now comprises three-quarters of documented COVID infections in the city.
It is "the most transmissible form of COVID-19 that we know of to date and may be more likely to infect people who have been vaccinated or already had COVID-19," the department tweeted. It didn't answer Just the News queries about the evidence for its claims about vaccination or prior infection.
The CDC said XBB.1.5 accounted for 43% of documented infections nationwide last week, with under 3% from BA.5, which is part of the bivalent cocktail. University of Tokyo virologists shared research Sunday that found XBB.1.5 exhibits "profound immune resistance" and "augmented ACE2 binding affinity," and hence "increased transmissibility," due to specific mutations.
While the World Health Organization deemed XBB variants "the most antibody-resistant variants to date" in a "rapid risk assessment" last week, it said XBB.1.5 specifically "does not carry any mutation known to be associated with potential change in severity."
The University of Lübeck researchers behind the Frontiers study confirmed the so-called IgG4 antibody "class switch" first observed by their peers at University of Erlangen-Nuremberg among healthcare workers in the Science Immunology paper, which was submitted 11 days earlier in August.
The Lübeck researchers recruited 157 people starting in December 2020 and split them into six groups, five of which had no known prior infection.
The first five received either two doses of Pfizer, Moderna or traditional AstraZeneca, or one dose of AstraZeneca followed by either a Pfizer or Moderna dose. The sixth group — infected but not hospitalized — received one or two Pfizer doses.
"[R]epeated immunization of [uninfected] individuals with the mRNA vaccines increased the proportion of the IgG4 subclass over time which might influence the long-term Ab [antibody] effector functions," according to the paper.
IgG4 is known for a mild immune response that "can even inhibit the effector functions of IgG1 and IgG3" antibodies, the researchers said. (Elsevier's ScienceDirect says IgG1 accounts for about 70% of total antibodies in adults, while IgG3 "mediates comparable functional activity.")
The groups that received any Moderna dose, whether a full primary series or just second dose, had a "higher potential to generate" long-term IgG4 responses compared to those who received any Pfizer dose, the paper says, speculating the higher mRNA concentration in Moderna might explain this.
Researchers didn't find a long-term IgG4 response in those who received two doses of AstraZeneca, the non-mRNA vaccine. (The study period was 270 days.)
The sixth group, with documented prior infection, which received the Pfizer vaccine, had "comparable long-term IgG subclass levels when compared to" uninfected Pfizer recipients, but "their IgG4 response seemed not to be or barely induced," the paper says. This result was "likely generated by re-activation" of memory B cells induced by natural infection.
https://justthenews.com/politics-policy/coronavirus/pfizer-fauci-staffers-sign-research-finding-mrna-covid-vaccines-produce
2 of 2 Fauci Demons sign off….
"If I were to choose between mRNA vaccines and adeno-vaccines based on these data alone, I would choose adeno-vaccine," University of Southern Denmark global health professor Christine Stabell Benn tweeted. She coauthored a paper last year finding that Pfizer and Moderna vaccines didn't reduce all-cause mortality, but it has not been published yet.
Pfizer and NIAID did not respond to Just the News queries on when they knew mRNA vaccines might induce a less effective antibody response, given their employees' involvement in editing and reviewing the Frontiers paper. Fauci stepped down as NIAID director at year's end, after his scientist completed peer review.
"The long-term impact of the switch to IgG4 antibodies is unclear," former New York Times drug industry reporter Alex Berenson wrote in his newsletter, which analyzed both IgG4 studies. "But nearly all the wealthy countries that heavily used the mRNA jabs continue to endure waves of Covid and significant numbers of deaths," particularly those with little prior infection such as Japan.
Without a stark change in across-the-board COVID vaccination policy, the U.S. stands to become even more heavily reliant on mRNA vaccines amid uncertainty over Johnson & Johnson's place in the market.
U.S. regulators crippled the reputation of J&J's traditional vaccine by recommending a "pause" to investigate a handful of blood clots in spring 2021. They did not repeat the pause when acknowledging heart inflammation reports in mRNA recipients that summer.
The Wall Street Journal reported last week that "slumping demand" led J&J to end manufacturing agreements for its traditional vaccine. It's also in arbitration with Merck, whose vaccine partnership was created under pressure from the Biden administration.
J&J said it has hundreds of millions of doses it will continue to make available "where needed," but didn't tell the Journal whether it will keep making its vaccine, which does not purport to target newer variants. The only other traditional COVID vaccine maker, Novavax, received authorization just six months ago.